Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
9.91 USD | +3.34% | -8.24% | +206.81% |
Mar. 18 | Arcutis Biotherapeutics, Inc.(NasdaqGS:ARQT) added to S&P Biotechnology Select Industry Index | CI |
Mar. 11 | Arcutis Promotes Todd Tucker to Chief Human Resources Officer | CI |
Evolution of the average Target Price on Arcutis Biotherapeutics, Inc.
Price target over the last 5 years
History of analyst recommendation changes
Analysts' Consensus
Consensus detail
Consensus revision (last 18 months)
Analysts covering Arcutis Biotherapeutics, Inc.
Mizuho Securities | |
Needham & Co. | |
Morgan Stanley | |
JonesTrading Institutional Services | |
Goldman Sachs | |
Truist Securities | |
Guggenheim |
EPS Revisions
- Stock
- Equities
- Stock Arcutis Biotherapeutics, Inc. - Nasdaq
- Consensus Arcutis Biotherapeutics, Inc.